These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis. Jin K; Shi Y; Zhang H; Zhangyuan G; Wang F; Li S; Chen C; Zhang J; Wang H; Zhang W; Sun B J Hepatol; 2023 Aug; 79(2):403-416. PubMed ID: 37040844 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease. Xu Y; Zhu Y; Hu S; Pan X; Bawa FC; Wang HH; Wang DQ; Yin L; Zhang Y Mol Metab; 2021 Sep; 51():101244. PubMed ID: 33930596 [TBL] [Abstract][Full Text] [Related]
5. Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution. Nozaki Y; Fujita K; Wada K; Yoneda M; Shinohara Y; Imajo K; Ogawa Y; Kessoku T; Nakamuta M; Saito S; Masaki N; Nagashima Y; Terauchi Y; Nakajima A BMC Gastroenterol; 2015 Dec; 15():177. PubMed ID: 26678309 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte-Specific Loss of PPARγ Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver. Lee SM; Pusec CM; Norris GH; De Jesus A; Diaz-Ruiz A; Muratalla J; Sarmento-Cabral A; Guzman G; Layden BT; Cordoba-Chacon J Cell Mol Gastroenterol Hepatol; 2021; 11(5):1291-1311. PubMed ID: 33444819 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis. Schröder T; Kucharczyk D; Bär F; Pagel R; Derer S; Jendrek ST; Sünderhauf A; Brethack AK; Hirose M; Möller S; Künstner A; Bischof J; Weyers I; Heeren J; Koczan D; Schmid SM; Divanovic S; Giles DA; Adamski J; Fellermann K; Lehnert H; Köhl J; Ibrahim S; Sina C Mol Metab; 2016 Apr; 5(4):283-295. PubMed ID: 27069868 [TBL] [Abstract][Full Text] [Related]
11. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression. Schulien I; Hockenjos B; Schmitt-Graeff A; Perdekamp MG; Follo M; Thimme R; Hasselblatt P Cell Death Differ; 2019 Sep; 26(9):1688-1699. PubMed ID: 30778201 [TBL] [Abstract][Full Text] [Related]
13. Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression. Bruinstroop E; Zhou J; Tripathi M; Yau WW; Boelen A; Singh BK; Yen PM Mol Metab; 2021 Nov; 53():101266. PubMed ID: 34098145 [TBL] [Abstract][Full Text] [Related]
14. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis. Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185 [TBL] [Abstract][Full Text] [Related]
15. Non-Alcoholic Fatty Liver Disease. Engin A Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211 [TBL] [Abstract][Full Text] [Related]
16. Protective and Detrimental Roles of p38α Mitogen-Activated Protein Kinase in Different Stages of Nonalcoholic Fatty Liver Disease. Hwang S; Wang X; Rodrigues RM; Ma J; He Y; Seo W; Park SH; Kim SJ; Feng D; Gao B Hepatology; 2020 Sep; 72(3):873-891. PubMed ID: 32463484 [TBL] [Abstract][Full Text] [Related]
18. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310 [TBL] [Abstract][Full Text] [Related]
19. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis. Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621 [TBL] [Abstract][Full Text] [Related]